M&A Deal Summary |
|
---|---|
Date | 2013-12-02 |
Target | Allergan - Obesity Intervention Division |
Sector | Medical Products |
Buyer(s) | Apollo Endosurgery |
Sellers(s) | Allergan |
Deal Type | Divestiture |
Deal Value | 110M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2005 |
Sector | Medical Products |
Apollo Endosurgery, Inc. (old) is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 500 million people globally, as well as other gastrointestinal disorders.
DEAL STATS | # |
---|---|
Overall | 2 of 2 |
Sector (Medical Products) | 1 of 1 |
Type (Divestiture) | 2 of 2 |
State (California) | 1 of 1 |
Country (United States) | 2 of 2 |
Year (2013) | 2 of 2 |
Size (of disclosed) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-10-29 |
Lap-Band System
United States The lap-band procedure, which involves inserting a band around a portion of the stomach to reduce its capacity and restrict the amount of food a patient can consume. |
Buy | $110M |
Category | Company |
---|---|
Founded | 1948 |
Sector | Life Science |
Employees | 11,400 |
Allergan, Inc. is a pharmaceutical company. Allergan's products include ophthalmic pharmaceuticals, dermatology products, and neurological products.
DEAL STATS | # |
---|---|
Overall | 2 of 3 |
Sector (Medical Products) | 1 of 1 |
Type (Divestiture) | 2 of 3 |
State (California) | 1 of 2 |
Country (United States) | 2 of 3 |
Year (2013) | 2 of 2 |
Size (of disclosed) | 3 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-10-29 |
Lap-Band System
United States The lap-band procedure, which involves inserting a band around a portion of the stomach to reduce its capacity and restrict the amount of food a patient can consume. |
Sell | $110M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-07-27 |
Allergan Generics
California, United States Allergan Generics is the generic drugs unit of Allergen Inc. |
Sell | $40.5B |